Benjamín Van Tassell

Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia–reperfusion in the mouse

Stefano Toldo, Carlo Marchetti, Adolfo G Mauro et al. · International Journal of Cardiology · 2016 · 225 citations

Immunology, Cell Death, Pathology +16

Medication nonadherence: an unrecognized cardiovascular risk factor.

Mark A. Munger, Benjamín Van Tassell, Joanne LaFleur · PubMed · 2007 · 224 citations

Hypertension, Heart Failure, Cardiovascular Pharmacology +16

Metabolic Gene Remodeling and Mitochondrial Dysfunction in Failing Right Ventricular Hypertrophy Secondary to Pulmonary Arterial Hypertension

Jose Gomez‐Arroyo, Shiro Mizuno, Karol Szczepanek et al. · Circulation Heart Failure · 2012 · 177 citations · Full text

Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II–III Systolic Heart Failure

George F. Wohlford, Benjamín Van Tassell, Hayley Billingsley et al. · Journal of Cardiovascular Pharmacology · 2020 · 138 citations · Full text

Heart Failure, Cardiovascular Pharmacology, Pharmacotherapy +18

The NLRP3 Inflammasome Inhibitor, OLT1177 (Dapansutrile), Reduces Infarct Size and Preserves Contractile Function After Ischemia Reperfusion Injury in the Mouse

Stefano Toldo, Adolfo G Mauro, Zachary Cutter et al. · Journal of Cardiovascular Pharmacology · 2019 · 136 citations · Full text